These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 8416750
21. Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX. de Vrij J, Uil TG, van den Hengel SK, Cramer SJ, Koppers-Lalic D, Verweij MC, Wiertz EJ, Vellinga J, Willemsen RA, Hoeben RC. Gene Ther; 2008 Jul; 15(13):978-89. PubMed ID: 18323790 [Abstract] [Full Text] [Related]
22. Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity. Dutoit V, Rubio-Godoy V, Dietrich PY, Quiqueres AL, Schnuriger V, Rimoldi D, Liénard D, Speiser D, Guillaume P, Batard P, Cerottini JC, Romero P, Valmori D. Cancer Res; 2001 Aug 01; 61(15):5850-6. PubMed ID: 11479225 [Abstract] [Full Text] [Related]
23. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide. Nishiyama T, Tachibana M, Horiguchi Y, Nakamura K, Ikeda Y, Takesako K, Murai M. Clin Cancer Res; 2001 Jan 01; 7(1):23-31. PubMed ID: 11205913 [Abstract] [Full Text] [Related]
24. MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma. Gibbs P, Hutchins AM, Dorian KT, Vaughan HA, Davis ID, Silvapulle M, Cebon JS. Melanoma Res; 2000 Jun 01; 10(3):259-64. PubMed ID: 10890380 [Abstract] [Full Text] [Related]
25. Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene. Chiari R, Foury F, De Plaen E, Baurain JF, Thonnard J, Coulie PG. Cancer Res; 1999 Nov 15; 59(22):5785-92. PubMed ID: 10582700 [Abstract] [Full Text] [Related]
26. A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry. Pascolo S, Schirle M, Gückel B, Dumrese T, Stumm S, Kayser S, Moris A, Wallwiener D, Rammensee HG, Stevanovic S. Cancer Res; 2001 May 15; 61(10):4072-7. PubMed ID: 11358828 [Abstract] [Full Text] [Related]
27. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis. Jenne L, Arrighi JF, Jonuleit H, Saurat JH, Hauser C. Cancer Res; 2000 Aug 15; 60(16):4446-52. PubMed ID: 10969791 [Abstract] [Full Text] [Related]
28. New tumour-restricted melanoma antigens as defined by cytotoxic T-cell responses. Parmiani G, Anichini A, Castelli C. Melanoma Res; 1997 Aug 15; 7 Suppl 2():S95-8. PubMed ID: 9578423 [Abstract] [Full Text] [Related]
29. Expression of A, G and B melanoma antigen genes in human hepatocellular carcinoma. Chen Z, Shao JB, Wu W. Hepatobiliary Pancreat Dis Int; 2002 Nov 15; 1(4):570-3. PubMed ID: 14607688 [Abstract] [Full Text] [Related]
30. Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients. Takahashi T, Irie RF, Morton DL, Hoon DS. Cell Immunol; 1997 Jun 15; 178(2):162-71. PubMed ID: 9225007 [Abstract] [Full Text] [Related]
31. The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides. Zhang XM, Zhang YF, Huang Y, Qu P, Ma B, Si SY, Li ZS, Li WX, Li X, Ge W, Hu PZ, Sui YF. Oncol Rep; 2008 Jul 15; 20(1):245-52. PubMed ID: 18575744 [Abstract] [Full Text] [Related]
32. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. Gaugler B, Van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethé B, Brasseur F, Boon T. J Exp Med; 1994 Mar 01; 179(3):921-30. PubMed ID: 8113684 [Abstract] [Full Text] [Related]
33. Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2. Ma W, Germeau C, Vigneron N, Maernoudt AS, Morel S, Boon T, Coulie PG, Van den Eynde BJ. Int J Cancer; 2004 May 01; 109(5):698-702. PubMed ID: 14999777 [Abstract] [Full Text] [Related]
34. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. Traversari C, van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar-Costesec A, Boon T. J Exp Med; 1992 Nov 01; 176(5):1453-7. PubMed ID: 1402688 [Abstract] [Full Text] [Related]
35. Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: implications for MAGE immunotherapy. Oaks MK, Hanson JP, O'Malley DP. Cancer Res; 1994 Apr 01; 54(7):1627-9. PubMed ID: 8137270 [Abstract] [Full Text] [Related]
36. Cloning and analysis of MAGE-1-related genes. Ding M, Beck RJ, Keller CJ, Fenton RG. Biochem Biophys Res Commun; 1994 Jul 15; 202(1):549-55. PubMed ID: 8037761 [Abstract] [Full Text] [Related]
37. [Establishment of B16-HLA-MAGE-3 melanoma cell line coexpressing HLA-A 0201/K(b) and MAGE-3 and its role in tumor vaccine evaluation]. Song SX, Yan CZ, Zheng L, You HY, Wang JX, Liu FY. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul 15; 24(7):679-82. PubMed ID: 18616910 [Abstract] [Full Text] [Related]
38. Expression spectrum and methylation-dependent regulation of melanoma antigen-encoding gene family members in pancreatic cancer cells. Bert T, Lubomierski N, Gangsauge S, Münch K, Printz H, Prasnikar N, Robbel C, Simon B. Pancreatology; 2002 Jul 15; 2(2):146-54. PubMed ID: 12123095 [Abstract] [Full Text] [Related]
39. Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Salgaller ML, Weber JS, Koenig S, Yannelli JR, Rosenberg SA. Cancer Immunol Immunother; 1994 Aug 15; 39(2):105-16. PubMed ID: 7519125 [Abstract] [Full Text] [Related]
40. Melanoma-associated antigen genes - an update. Sang M, Wang L, Ding C, Zhou X, Wang B, Wang L, Lian Y, Shan B. Cancer Lett; 2011 Mar 28; 302(2):85-90. PubMed ID: 21093980 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]